A mini review of node centrality metrics in biological networks

M Wang, H Wang, H Zheng - International Journal of Network …, 2022 - pure.ulster.ac.uk
The diversity of nodes in a complex network causes each node to have varying significance,
and the important nodes often have a significant impact on the structure and function of the …

Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers

R Liu, X Wang, K Aihara, L Chen - Medicinal research reviews, 2014 - Wiley Online Library
Many studies have been carried out for early diagnosis of complex diseases by finding
accurate and robust biomarkers specific to respective diseases. In particular, recent rapid …

Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers

L Chen, R Liu, ZP Liu, M Li, K Aihara - Scientific reports, 2012 - nature.com
Considerable evidence suggests that during the progression of complex diseases, the
deteriorations are not necessarily smooth but are abrupt and may cause a critical transition …

Personalized characterization of diseases using sample-specific networks

X Liu, Y Wang, H Ji, K Aihara, L Chen - Nucleic acids research, 2016 - academic.oup.com
A complex disease generally results not from malfunction of individual molecules but from
dysfunction of the relevant system or network, which dynamically changes with time and …

[图书][B] Fundamentals of complex networks: models, structures and dynamics

G Chen, X Wang, X Li - 2015 - books.google.com
Complex networks such as the Internet, WWW, transportation networks, power grids,
biological neural networks, and scientific cooperation networks of all kinds provide …

Multiomics network medicine approaches to precision medicine and therapeutics in cardiovascular diseases

RS Wang, BA Maron, J Loscalzo - Arteriosclerosis, thrombosis, and …, 2023 - Am Heart Assoc
Cardiovascular diseases (CVD) are the leading cause of death worldwide and display
complex phenotypic heterogeneity caused by many convergent processes, including …

Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways

L Yu, M Wang, Y Yang, F Xu, X Zhang… - PLoS Computational …, 2021 - journals.plos.org
Hepatocellular carcinoma (HCC) is a significant health problem worldwide with poor
prognosis. Drug repositioning represents a profitable strategy to accelerate drug discovery …

Network-based drug repositioning

Z Wu, Y Wang, L Chen - Molecular BioSystems, 2013 - pubs.rsc.org
Network-based computational biology, with the emphasis on biomolecular interactions and
omics-data integration, has had success in drug development and created new directions …

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds

B He, F Hou, C Ren, P Bing, X Xiao - Frontiers in Oncology, 2021 - frontiersin.org
Drug repositioning is a new way of applying the existing therapeutics to new disease
indications. Due to the exorbitant cost and high failure rate in developing new drugs, the …

Big biological data: challenges and opportunities

Y Li, L Chen - Genomics, Proteomics and Bioinformatics, 2014 - academic.oup.com
In ''Omics''era of the life sciences, data is presented in many forms, which represent the
information at various levels of biological systems, including data about genome …